HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasma pharmacokinetics, pulmonary distribution, and in vitro activity of gamithromycin in foals.

Abstract
The objectives of this study were to determine the plasma and pulmonary disposition of gamithromycin in foals and to investigate the in vitro activity of the drug against Streptococcus equi subsp. zooepidemicus (S. zooepidemicus) and Rhodococcus equi. A single dose of gamithromycin (6 mg/kg of body weight) was administered intramuscularly. Concentrations of gamithromycin in plasma, pulmonary epithelial lining fluid (PELF), bronchoalveolar lavage (BAL) cells, and blood neutrophils were determined using HPLC with tandem mass spectrometry detection. The minimum inhibitory concentration of gamithromycin required for growth inhibition of 90% of R. equi and S. zooepidemicus isolates (MIC(90)) was determined. Additionally, the activity of gamithromycin against intracellular R. equi was measured. Mean peak gamithromycin concentrations were significantly higher in blood neutrophils (8.35±1.77 μg/mL) and BAL cells (8.91±1.65 μg/mL) compared with PELF (2.15±2.78 μg/mL) and plasma (0.33±0.12 μg/mL). Mean terminal half-lives in neutrophils (78.6 h), BAL cells (70.3 h), and PELF (63.6 h) were significantly longer than those in plasma (39.1 h). The MIC(90) for S. zooepidemicus isolates was 0.125 μg/mL. The MIC of gamithromycin for macrolide-resistant R. equi isolates (MIC(90)=128 μg/mL) was significantly higher than that for macrolide-susceptible isolates (1.0 μg/mL). The activity of gamithromycin against intracellular R. equi was similar to that of azithromycin and erythromycin. Intramuscular administration of gamithromycin at a dosage of 6 mg/kg would maintain PELF concentrations above the MIC(90) for S. zooepidemicus and phagocytic cell concentrations above the MIC(90) for R. equi for approximately 7 days.
AuthorsL J Berghaus, S Giguère, T L Sturgill, D Bade, T J Malinski, R Huang
JournalJournal of veterinary pharmacology and therapeutics (J Vet Pharmacol Ther) Vol. 35 Issue 1 Pg. 59-66 (Feb 2012) ISSN: 1365-2885 [Electronic] England
PMID21443748 (Publication Type: Journal Article)
Copyright© 2011 Blackwell Publishing Ltd.
Chemical References
  • Anti-Bacterial Agents
  • Macrolides
  • gamithromycin
Topics
  • Animals
  • Anti-Bacterial Agents (blood, metabolism, pharmacokinetics)
  • Female
  • Horses (blood, metabolism)
  • Lung (metabolism)
  • Macrolides (blood, metabolism, pharmacokinetics)
  • Male
  • Microbial Sensitivity Tests
  • Rhodococcus equi (drug effects)
  • Streptococcus equi (drug effects)
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: